Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
10:20am, Monday, 12'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for IBB
Amgen (NASDAQ:AMGN) – Here's Why Amgen Shares Are Diving
09:27am, Monday, 12'th Sep 2022
Amgen, Inc. (NASDAQ: AMGN) shares are trading lower by 4.11% to $237.51 during Monday's pre-market session following FDA approval of Bristol Myers Squibb Co's (NYSE: BMY) plaque psoriasis drug Sotykt
Amgen says Lumakras cuts risk of lung cancer progression by 34%
06:08pm, Sunday, 11'th Sep 2022
Amgen Inc's Lumakras pill reduced the risk of disease progression in patients with advanced lung cancer by 34% compared with chemotherapy in a clinical trial, the company said on Sunday.
Best Stocks To Buy Now? 4 Biotech Stocks In Focus
12:10pm, Sunday, 11'th Sep 2022
Is now a good time to add these biotech stocks to your watchlist?
Amgen (AMGN) Gains But Lags Market: What You Should Know
09:45pm, Friday, 09'th Sep 2022 Zacks Investment Research
Amgen (AMGN) closed at $247.69 in the latest trading session, marking a +0.91% move from the prior day.
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
02:23pm, Friday, 09'th Sep 2022 The Motley Fool
Amgen's biosimilar drug is close to stealing away sales from AstraZeneca's rare disease drug called Soliris.
The Zacks Analyst Blog Highlights: T-Mobile US, NextEra Energy, Amgen, 3M and Itau Unibanco Holding
11:57am, Friday, 09'th Sep 2022 Zacks Investment Research
T-Mobile US, NextEra Energy, Amgen, 3M and Itau Unibanco Holding are part of The Zacks top Analyst Blog .
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
10:23am, Friday, 09'th Sep 2022
Amgen's biosimilar drug is close to stealing away sales from AstraZeneca's rare disease drug called Soliris.
Top Stock Reports for T-Mobile, NextEra Energy & Amgen
10:15pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), NextEra Energy, Inc. (NEE) and Amgen Inc. (AMGN).
Cancer-Drug Maker's Solid Position And Successful Drug Record Drive Growth
05:09pm, Thursday, 08'th Sep 2022
Cancer-drug maker Amgen solidified its position in a highly competitive market by acquiring its rival Mirati Therapeutics.
Amgen Inc. (AMGN) Presents at 2022 Wells Fargo Healthcare Conference (Transcript)
12:30pm, Thursday, 08'th Sep 2022
Amgen Inc. (NASDAQ:AMGN ) 2022 Wells Fargo Healthcare Conference September 8, 2022 9:45 AM ET Company Participants Peter Griffith - Chief Financial Officer David Reese - Executive Vice President of Re
Should You Invest in the iShares Biotechnology ETF (IBB)?
10:20am, Thursday, 08'th Sep 2022 Zacks Investment Research
Sector ETF report for IBB
Amgen (AMGN) Gains But Lags Market: What You Should Know
09:50pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Amgen (AMGN) closed the most recent trading day at $244.79, moving +1.06% from the previous trading session.
Amgen Inc. (AMGN) 2022 Citi Global Technology Conference (Transcript)
03:32pm, Wednesday, 07'th Sep 2022
Amgen Inc. (NASDAQ:AMGN ) 2022 Citi Global Technology Conference Call September 7, 2022 8:50 AM ET Company Participants Peter Griffith - Chief Financial Officer David Reese - Executive Vice President
What's Driving Amgen Stock Higher?
05:00am, Wednesday, 07'th Sep 2022
Amgen stock (NASDAQ: AMGN) has seen an 8% rise this year, far better than the broader S&P500 index, which is down 18%.
